Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
Titel:
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
Auteur:
Long, G.V. Carlino, M.S. McNeil, C. Ribas, A. Gaudy-Marqueste, C. Schachter, J. Nyakas, M. Kee, D. Petrella, T.M. Blaustein, A. Lotem, M. Arance, A.M. Daud, A.I. Hamid, O. Larkin, J. Yao, L. Singh, R. Lal, R. Robert, C.